# Chicago Atlantic Real Estate Finance, Inc.: overview REFI · Nasdaq · CIK 1867949 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/refi.md) · [Financials](/companies/refi/financials.md) · [Filings](/companies/refi/filings.md) · [Insiders](/companies/refi/insiders.md) Latest reported revenue: [$13.7m](/filings/0001213900-23-064752.md) for Q2 FY2023, three months to 2023-06-30, from the 10-Q filed Aug 9, 2023 (XBRL us-gaap:Revenues, accession 0001213900-23-064752). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.56](/filings/0001193125-25-263522.md) | not reported | [0.47](/filings/0001193125-26-210274.md) | [0.41](/filings/0001193125-26-343398.md) | [0.42](/filings/0001193125-25-263522.md) | not reported | [0.23](/filings/0001193125-26-210274.md) | [0.34](/filings/0001193125-26-343398.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | | Revenue | $m | [48.9](/filings/0001213900-23-018678.md) | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | | Net margin | % | [66.1%](/filings/0000950170-24-029644.md) | not reported | not reported | not reported | | Diluted EPS | $ per share | [1.82](/filings/0000950170-24-029644.md) | [2.11](/filings/0000950170-25-037616.md) | [1.88](/filings/0001193125-26-103027.md) | [1.68](/filings/0001193125-26-103027.md) | | Free cash flow | $m | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/refi/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $18.4m | 1,719,049 | | Added +293,478 | | [Fielder Capital Group LLC](/funds/2010765.md) | 2026-06-30 | $10.5m | 982,283 | | Added +22,483 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $8.5m | 788,254 | | Added +60,401 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $5.6m | 499,188 | | Reduced −11,345 | | [SEGALL BRYANT & HAMILL, LLC](/funds/1006378.md) | 2026-06-30 | $2.0m | 188,621 | | New +188,621 | | [CDC Financial, Inc.](/funds/2077836.md) | 2026-06-30 | $1.8m | 163,704 | | Added +22,154 | | [Clayton Partners LLC](/funds/1550509.md) | 2026-06-30 | $1.7m | 155,344 | | Added +5,000 | | [Corient Private Wealth LP](/funds/1948780.md) | 2026-06-30 | $1.6m | 152,719 | | Reduced −3,498 | | [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $1.6m | 146,958 | | Added +5,485 | | [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $1.3m | 125,772 | | Added +21,439 | ## Recent filings [All 210 filings](/companies/refi/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-11 | 07:02 ET | [8-K](/filings/0001213900-26-087484.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-087484 | | 2026-08-11 | 07:00 ET | [10-Q](/filings/0001193125-26-343398.md) | Quarterly report, period 2026-06-30 | 0001193125-26-343398 | | 2026-07-13 | 16:30 ET | [8-K](/filings/0001213900-26-077585.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-077585 | | 2026-06-18 | 07:30 ET | [8-K](/filings/0001213900-26-069861.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-069861 | | 2026-06-11 | 16:15 ET | [8-K](/filings/0001213900-26-067830.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-067830 | | 2026-05-07 | 07:01 ET | [8-K](/filings/0001213900-26-053036.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-053036 | | 2026-05-07 | 07:00 ET | [10-Q](/filings/0001193125-26-210274.md) | Quarterly report, period 2026-03-31 | 0001193125-26-210274 | | 2026-04-23 | 07:00 ET | [DEF 14A](/filings/0001193125-26-171796.md) | Proxy statement, period 2026-04-22 | 0001193125-26-171796 | | 2026-03-12 | 07:01 ET | [8-K](/filings/0001213900-26-026631.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-026631 | | 2026-03-12 | 07:00 ET | [10-K](/filings/0001193125-26-103027.md) | Annual report, period 2025-12-31 | 0001193125-26-103027 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-103027.md), filed Mar 12, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1867949 - Tickers: REFI - Exchange: Nasdaq - SIC code: 6798 Real Estate Investment Trusts - State of incorporation: MD - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.